Growth Metrics

Harmony Biosciences Holdings (HRMY) Cash from Investing Activities (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Cash from Investing Activities for 7 consecutive years, with -$17.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 145.35% to -$17.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$39.6 million through Dec 2025, up 41.25% year-over-year, with the annual reading at -$39.6 million for FY2025, 41.25% up from the prior year.
  • Cash from Investing Activities hit -$17.6 million in Q4 2025 for Harmony Biosciences Holdings, down from -$4.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q1 2025 to a low of -$100.0 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged -$20.8 million across 5 years, with a median of -$7.8 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: crashed 34787.1% in 2022 and later surged 191.64% in 2024.
  • Year by year, Cash from Investing Activities stood at -$93000.0 in 2021, then plummeted by 50324.73% to -$46.9 million in 2022, then grew by 23.09% to -$36.1 million in 2023, then surged by 80.07% to -$7.2 million in 2024, then plummeted by 145.35% to -$17.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for HRMY at -$17.6 million in Q4 2025, -$4.8 million in Q3 2025, and -$19.6 million in Q2 2025.